Answers are grounded in this paper and cite their sources.
Demonstrates improved drug-protein affinity prediction using AI and quantum chemistry, highlighting its real-world applications.
In recent years, there has been a surge in artificial intelligence (AI)-based drug–protein (or pesticide–protein) affinity (DPA) prediction tools. The field has been primarily driven by evolving deep-learning architectures and increasingly complex representations, leading to a growing demand for training data sourced from limited experimental data. In this work, we present DeepDOX1, a dual-drive DPA prediction tool featuring the tight integration of a concise AI architecture and an interpretable, quantum chemistry-based representation of protein–ligand interactions. To be more specific, the first-principles quantum chemistry-generated features incorporating the interactions between the drug and the protein binding pocket allow a relatively simple convolutional neural network (CNN) model trained on a relatively small training set (9,938 binders) to exhibit exceptional generalization capabilities across extensive testing involving 1,281 binders. Notably, DeepDOX1 outperforms popular AI-based DPA prediction methods in the tests simulating real-world hit-to-lead optimization (HLO) scenarios and a highly challenging test set featuring covalent ligands, halogenated ligands, and metalloproteins, even though its training set does not contain any covalent ligands. To further validate its practical utility, we designed a series of novel covalent inhibitors targeting the diabetes target molecule Hu-FBPase using DeepDOX1. Subsequent experimental validation, including enzyme-level bioactivity assays and crystal structure determination, revealed strengthened activity of the newly designed compound and confirmed DeepDOX1’s effectiveness in real-world drug design applications. It is conceivable that the combination of deep-learning architecture and first-principles quantum chemistry might be one of the next breakthroughs in DPA prediction.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: